SPDR S&P Biotech (XBI) - Stock Price & Dividends

Exchange: USA Stocks • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A8707 • Health

The SPDR® S&P Biotech ETF (NYSE ARCA:XBI) aims to mirror the performance of the S&P Biotechnology Select Industry Index through a sampling approach. This fund typically invests almost all, with a minimum of 80%, of its assets in the index's securities, which encompass the biotechnology sector within the S&P Total Market Index.

The index, reflecting the biotechnology industry within the broader S&P TMI, provides investors with an opportunity to gain exposure to this specific segment of the market. By primarily investing in holdings from this index, the fund offers a chance to participate in the potential growth and performance of the biotechnology industry.

For further information on the SPDR® S&P Biotech ETF (NYSE ARCA:XBI), including specific details on its performance, holdings, fees, and more, you can visit the official website at http://www.spdrs.com. The fund is based in the United States, providing investors with access to the biotechnology sector within a diversified investment portfolio.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for SPDR S&P Biotech (XBI) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for SPDR S&P Biotech (XBI) - Stock Price & Dividends

XBI ETF Overview

Market Cap in USD 7,911m
Category Health
TER 0.35%
IPO / Inception 2006-01-31

XBI ETF Ratings

Fundamental -
Dividend 5.08
Growth 5y -0.18
Rel. Performance vs Sector -0.57
Analysts -
Fair Price Momentum 85.73 USD
Fair Price DCF -

XBI Dividends

Yield 12m 0.02%
Yield on Cost 5y 0.02%
Dividends CAGR 5y 32.44%
Payout Consistency 51.2%

XBI Growth Ratios

Growth 12m 24.38%
Growth Correlation 12m 20%
Growth Correlation 3m 41%
CAGR 5y 1.02%
Sharpe Ratio 12m 0.67
Alpha vs SP500 12m -10.18
Beta vs SP500 5y weekly 1.09
ValueRay RSI 43.37
Volatility GJR Garch 1y 30.65%
Price / SMA 50 1.86%
Price / SMA 200 15.17%
Current Volume 12168.9k
Average Volume 20d 11747.3k

External Links for XBI ETF

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of XBI stocks?
As of March 28, 2024, the stock is trading at USD 94.91 with a total of 12,168,850 shares traded.
Over the past week, the price has changed by -0.26%, over one month by -7.76%, over three months by +4.49% and over the past year by +26.66%.
What is the forecast for XBI stock price target?
According to ValueRays Forecast Model, XBI SPDR S&P Biotech will be worth about 95.8 in March 2025. The stock is currently trading at 94.91. This means that the stock has a potential upside of +0.93%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 95.8 0.93%